scPharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

BURLINGTON, Mass., Feb. 05, 2025 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH) (the “Company”), a pharmaceutical company committed to revolutionizing cardiorenal healthcare through patient-centric innovations, today announced that John Tucker, President & Chief Executive Officer, will present at the Oppenheimer 35^th Annual Healthcare Life Sciences Conference on Wednesday, February 12 at 2:40PM ET.